Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 286

1.

Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder.

Papakostas GI, Petersen TJ, Kinrys G, Burns AM, Worthington JJ, Alpert JE, Fava M, Nierenberg AA.

J Clin Psychiatry. 2005 Oct;66(10):1326-30.

PMID:
16259548
[PubMed - indexed for MEDLINE]
2.

Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.

Papakostas GI, Petersen TJ, Nierenberg AA, Murakami JL, Alpert JE, Rosenbaum JF, Fava M.

J Clin Psychiatry. 2004 Feb;65(2):217-21.

PMID:
15003076
[PubMed - indexed for MEDLINE]
3.

An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression.

Rutherford B, Sneed J, Miyazaki M, Eisenstadt R, Devanand D, Sackeim H, Roose S.

Int J Geriatr Psychiatry. 2007 Oct;22(10):986-91.

PMID:
17340654
[PubMed - indexed for MEDLINE]
4.

An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.

Iosifescu DV, Nierenberg AA, Mischoulon D, Perlis RH, Papakostas GI, Ryan JL, Alpert JE, Fava M.

J Clin Psychiatry. 2005 Aug;66(8):1038-42.

PMID:
16086620
[PubMed - indexed for MEDLINE]
5.

Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.

Simon JS, Nemeroff CB.

J Clin Psychiatry. 2005 Oct;66(10):1216-20.

PMID:
16259533
[PubMed - indexed for MEDLINE]
6.

Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants.

Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, McQuade RD, Carson WH, Adson D, Taylor L, Hazel J, Marcus RN.

CNS Spectr. 2009 Apr;14(4):197-206.

PMID:
19407731
[PubMed - indexed for MEDLINE]
7.

Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.

Sheffrin M, Driscoll HC, Lenze EJ, Mulsant BH, Pollock BG, Miller MD, Butters MA, Dew MA, Reynolds CF 3rd.

J Clin Psychiatry. 2009 Feb;70(2):208-13. Epub 2009 Feb 10.

PMID:
19210951
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.

Lin CH, Lin SH, Jang FL.

J Clin Psychopharmacol. 2011 Oct;31(5):563-8. doi: 10.1097/JCP.0b013e31822bb0db.

PMID:
21869699
[PubMed - indexed for MEDLINE]
9.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
[PubMed - indexed for MEDLINE]
10.

Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.

Trivedi MH, Thase ME, Fava M, Nelson CJ, Yang H, Qi Y, Tran QV, Pikalov A, Carlson BX, Marcus RN, Berman RM.

J Clin Psychiatry. 2008 Dec;69(12):1928-36. Epub 2008 Dec 2.

PMID:
19192475
[PubMed - indexed for MEDLINE]
11.

A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.

Dunn RT, Stan VA, Chriki LS, Filkowski MM, Ghaemi SN.

J Affect Disord. 2008 Sep;110(1-2):70-4. doi: 10.1016/j.jad.2008.01.004. Epub 2008 Feb 12.

PMID:
18272230
[PubMed - indexed for MEDLINE]
12.

A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study).

Fava M, Mischoulon D, Iosifescu D, Witte J, Pencina M, Flynn M, Harper L, Levy M, Rickels K, Pollack M.

Psychother Psychosom. 2012;81(2):87-97. doi: 10.1159/000332050. Epub 2012 Jan 25. Erratum in: Psychother Psychosom. 2012;81(4):261.

PMID:
22286203
[PubMed - indexed for MEDLINE]
13.

The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.

Dording C, Cassiello C, King F 4th, Pencina M, Fava M, Mischoulon D.

Int Clin Psychopharmacol. 2013 Sep;28(5):238-44. doi: 10.1097/YIC.0b013e32836220df.

PMID:
23764521
[PubMed - indexed for MEDLINE]
14.

An open study of aripiprazole and escitalopram for psychotic major depressive disorder.

Matthews JD, Siefert C, Dording C, Denninger JW, Park L, van Nieuwenhuizen AO, Sklarsky K, Hilliker S, Homberger C, Rooney K, Fava M.

J Clin Psychopharmacol. 2009 Feb;29(1):73-6. doi: 10.1097/JCP.0b013e318193dfb4.

PMID:
19142112
[PubMed - indexed for MEDLINE]
15.

Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study.

Fabrazzo M, Perris F, Monteleone P, Esposito G, Catapano F, Maj M.

Eur Neuropsychopharmacol. 2012 Feb;22(2):132-6. doi: 10.1016/j.euroneuro.2011.06.006. Epub 2011 Jul 23.

PMID:
21784621
[PubMed - indexed for MEDLINE]
16.

Efficacy and tolerability of aripiprazole augmentation in sertraline-resistant patients with borderline personality disorder.

Bellino S, Paradiso E, Bogetto F.

Psychiatry Res. 2008 Nov 30;161(2):206-12. doi: 10.1016/j.psychres.2007.07.006. Epub 2008 Oct 9.

PMID:
18848360
[PubMed - indexed for MEDLINE]
17.

Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder.

Masi G, Pfanner C, Millepiedi S, Berloffa S.

J Clin Psychopharmacol. 2010 Dec;30(6):688-93.

PMID:
21105283
[PubMed - indexed for MEDLINE]
18.

Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: a post-hoc, pooled analysis of two large, placebo-controlled studies.

Nelson JC, Mankoski R, Baker RA, Carlson BX, Eudicone JM, Pikalov A, Tran QV, Berman RM.

J Affect Disord. 2010 Jan;120(1-3):133-40. doi: 10.1016/j.jad.2009.06.026. Epub .

PMID:
19656577
[PubMed - indexed for MEDLINE]
19.

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

Berman RM, Marcus RN, Swanink R, McQuade RD, Carson WH, Corey-Lisle PK, Khan A.

J Clin Psychiatry. 2007 Jun;68(6):843-53.

PMID:
17592907
[PubMed - indexed for MEDLINE]
20.

Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients.

Worthington JJ 3rd, Kinrys G, Wygant LE, Pollack MH.

Int Clin Psychopharmacol. 2005 Jan;20(1):9-11.

PMID:
15602109
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk